Abbvie
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. Please visit us at www.abbvie.com
Advanced Accelerator Applications, a Novartis company
Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is developing targeted radioligand therapies and precision imaging radioligands for oncology indications. We are leading innovators in nuclear medicine for the benefit of our patients.
Agendia
Agendia manufactures genomic tests to help physicians navigate the complexities of breast cancer. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help patients make informed treatment decisions. Learn more: agendia.com
Alkermes
Alkermes is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology.
Amgen
A biotechnology pioneer since 1980, Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Astellas
Astellas is a pharmaceutical company committed to turning innovative science into value for patients. Changing tomorrow is the ethos that guides everything we do.
AstraZeneca
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes marketed products and clinical development compounds, with the aim to impact the way cancer is treated.
BeiGene, LTD.
BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide
Bionano Genomics
Optical Genome Mapping with Bionano Saphyr® is a non-sequencing technique that provides a high-resolution view of intact, long DNA molecules free from the bias and errors introduced by NGS, genome-wide and at sensitivity down to 1% allele fraction.
Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com.
Boehringer Ingelheim International GmbH
Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim Oncology, we are providing new hope for patients, by taking cancer on.
Boston Scientific
Boston Scientific puts patients first, and in Intervention Oncology our mission is to change the fight against cancer through personalized strategies and a best-in-class portfolio supported by evidence and education partnerships.
Calithera Biosciences
Calithera develops small molecule therapeutics that target tumor metabolism. Telaglenastat, a glutaminase inhibitor, is being evaluated in combination with chemoimmunotherapy in a 1L trial in patients with NSCLC with KEAP1/NRF2 mutations.
Caris Life Sciences
Caris Life Sciences® is a leading innovator in molecular science & artificial intelligence focused on fulfilling the promise of precision medicine through quality & innovation. To learn more, visit www.CarisLifeSciences.com or on Twitter (@CarisLS).
Cerba Research
Headquartered in Belgium, Cerba Research is a Global Central & Specialist Laboratory. Our footprint includes 6 harmonized lab locations in Ghent, New York, Johannesburg, Shanghai, Taipei & Sydney, expert in oncology, infectious diseases, and more.
Clovis Oncology
Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Coherus BioSciences
Coherus is dedicated to improving the availability of high-quality, high-value medicines that can have a major impact on patients’ lives. Coherus is developing a leading immune-oncology franchise building upon its success with biosimilars.
Daiichi Sankyo
With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.
Deciphera Pharmaceuticals
Deciphera is focused on discovering, developing, and delivering important new medicines for the treatment of cancer. Using our proprietary switch-control kinase inhibitor platform, we have developed a broad portfolio of innovative medicines.
Eisai Europe Ltd
Eisai EMEA is dedicated to giving first thoughts to patients & their families through our human health care philosophy. We are the European hub of Eisai Co Ltd forming part of a multinational team working across a global network of R&D facilities.
Eli Lilly and Company
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better.
Exact Sciences
Exact Sciences is a leading, global cancer diagnostics company. From early detection to diagnosis and treatment decisions, the company is offering and further developing a suite of tests to enable personalised care at all stages of the disease.
Exelixis Inc
Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers.
F. Hoffmann-La Roche Ltd
About Roche. Roche is a pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, hematology, and beyond.
Genmab
Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. To create novel therapies, Genmab utilizes its next-gen antibody technologies and its pipeline consists of modified antibody candidates.
Gilead Sciences, Inc.
Gilead and Kite Oncology focuses on delivering therapies for some of the most difficult-to-treat cancers. We aim to change how cancer is treated with an antibody-drug conjugate, targeting immune evasion pathways and harnessing the power of cell therapy.
GSK
GSK is focused on maximising patient survival through transformational medicines. Our goal is to achieve a sustainable flow of new treatments in immuno-oncology, cell therapy, cancer epigenetics and synthetic lethality.
Guardant Health
A leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Guardant360 CDx is the first FDA-approved comprehensive liquid biopsy for all advanced solid tumors.
Helsinn Healthcare
Helsinn, a Swiss Pharma Group with an extensive portfolio of marketed innovative cancer and rare disease therapies, a robust drug development pipeline committed to improving the everyday lives of patients and addressing address unmet medical needs.
Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.
Ipsen
Ipsen is a global biopharmaceutical company focused on transformative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases.
Janssen Oncology
We pursue the cancer types and sub-types that we know best, and where we can achieve the highest impact – both in transforming patients’ lives today and in moving closer to a cure tomorrow.
Kaiku Health
Kaiku Health is a digital therapeutics platform for cancer care. It enables digital patient-reported outcome monitoring and intelligent symptom tracking. Real-world data for clinicians. Seamless care experience for patients.
Kyowa Kirin
Kyowa Kirin is an R&D-based life sciences company which strives to contribute to the health and well-being of people around the world through the pursuit of advances in life science and technologies. We wish all delegates a successful congress.
Labcorp
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Learn more about Labcorp at www.labcorp.com
medac GmbH
medac is a privately held, global pharmaceutical and diagnostics company. Since its foundation medac has been specialising in the treatment of diseases within the indication areas oncology, haematology, urology and autoimmune disorders.
Medscape Oncology
Medscape Oncology is the leading online destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives and providing continuing medical education in a variety of engaging formats.
Menarini Silicon Biosystems
Menarini Silicon Biosystems offers unique rare cell technologies and solutions. CELLSEARCH® and DEPArray™ together provide an end-to-end workflow solution for the enumeration, isolation, and molecular characterization of CTCs in liquid biopsy.
Merck KGaA Darmstadt, Germany
At Merck KGaA, Darmstadt, Germany, our scientific approach in oncology focuses on oncogenic pathways, immuno-oncology, and DNA damage response. We aim to deliver personalized treatment options that may potentially transform cancer care.
Molecular Health
Molecular Health stands for transforming big clinical data into better treatment decisions. With MH Guide, we analyze molecular and clinical data of patients and compare it to the world’s up-to-date medical, biological, and pharmacological knowledge.
MSD
At MSD, our goal is to translate breakthrough science into innovative oncology medicines. As part of our focus on cancer, MSD is committed to clinical research with one of the largest development programs in the industry.
Natera, Inc.
Natera has developed Signatera, a personalized ctDNA test for molecular residual disease detection and recurrence monitoring. Signatera's tumor-informed test has been validated in multiple solid tumors for immunotherapy response monitoring.
NeoGenomics Laboratories
NeoGenomics is an industry-leading cancer diagnostics and pharma services company. We partner closely with our pharma clients to meet program objectives and delivery from discovery through CDx commercialization.
Novartis Oncology
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need.
Novocure GmbH
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields.
Oncology Learning Network
Oncology Learning Network is an interactive, online resource for the latest developments in oncology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.
OSE Immunotherapeutics
OSE Immunotherapeutics is a French clinical-stage biotechnology company focused on research & development of innovative immunotherapies in immuno-oncology and autoimmune diseases and partnering them with academic research and pharmaceutical companies.
Pfizer Oncology
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Visit Pfizer.com to learn more.
PharmaMar
PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. PharmaMar develops and commercializes Yondelis® in Europe.
Philips Molecular Pathway Diagnostics
OncoSignal quantifies the activity of signal transduction pathways that drive tumor growth with the potential to offer actionable therapy response prediction for personalized cancer treatment decisions. Offered as service or for in-house testing.
Pierre Fabre
Pierre Fabre is a French pharmaceutical and dermo-cosmetic company. Oncology is one of its top priorities, focusing on targeted therapies, biotherapies and immuno-oncology, in therapeutic areas such as colorectal, breast, lung cancers and melanoma.
Precision for Medicine
A global full service CRO, Precision integrates trials, labs, and data to maximize insight into patient biology. We master complexity in oncology, rare disease, and cell and gene therapy development, speeding life-changing treatments to market.
Sanofi Genzyme
Sanofi Genzyme focuses on developing therapies in oncology, rare diseases, rare blood disorders, multiple sclerosis, and immunology. Learn more about how Sanofi is providing meaningful solutions to patients with cancer and their families.
Science4Tech Solutions (S4T)
MatchTrial is a technological solution which accelerates and speeds up the search of potential candidates for oncology clinical trials. We offer an efficient and effective tool in order to find a trial for patients in just few minutes.
Seagen
Seagen discovers, develops and commercializes novel medicines for cancer. For more information, visit:
Servier
To respond to the growing need for therapeutic solutions, Servier has made oncology a priority. Servier’s development program in oncology includes 19 projects, in both monoclonal antibodies and targeted small molecules.
SOPHiA GENETICS
SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine to improve health outcomes and economics worldwide. The universal SOPHiA DDM Platform allows clinical researchers to act with precision and confidence.
SOTIO a.s.
SOTIO is a clinical stage immune-oncology company. SOTIO’s clinical pipeline includes an IL-15 superagonist, a platform to streamline personalized active immune cell therapies, CAR T platform and a new generation of antibody-drug conjugates.
Stemline Therapeutics
Stemline Therapeutics – a Menarini Group Company - is dedicated to raising awareness of blastic plasmacytoid dendritic cell neoplasm (BPDCN) a rare and aggressive hematological malignancy.
Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Learn how we help customers shorten the distance from lab to life® at:
Sysmex Inostics, Inc.
Sysmex Inostics empowers diagnostic and therapeutic discoveries in oncology by providing investigators cost-effective and ultra-sensitive quantitative liquid biopsy solutions, SafeSEQ (NGS) and OncoBEAM™ (digital PCR).
Taiho Oncology, Inc.
Taiho Oncology, Inc. works urgently to discover and develop innovative cancer treatments. As cancer evolves, we evolve with it-bringing novel technology to cornerstone chemotherapies, while at the same time optimizing new targeted agents.
Takeda Pharmaceuticals
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. For more information, visit www.takedaoncology.com.
Tempus
Through our smart genomic profiling tests and targeted clinical trial matching, Tempus informs treatment options for your patients at every point of their journey, transforming treatment over time.
Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. Our “Easy NGS solution” can deliver results for 50 key oncology biomarkers in unprecedented 1 day.
Viatris
VIATRIS is a new kind of healthcare company, committed to providing access to medicines.